US stock return on invested capital analysis and economic value added calculations to identify truly exceptional businesses. Our quality metrics help you find companies that generate superior returns on capital employed.
As of April 16, 2026, The Oncology Institute Inc. (TOI) is trading at $3.54, posting an intraday gain of 3.21% during regular market hours. This analysis examines key technical price levels for TOI, recent market context for the specialty oncology care sector, and potential short-term price scenarios that market participants may monitor. No recently released quarterly earnings data is available for TOI at the time of writing, so current price action is largely being driven by technical flows and
The (TOI) Stock: Valuation Metrics (+3.21%) 2026-04-16 - Buy Opportunities
TOI - Stock Analysis
4106 Comments
1321 Likes
1
Kearria
Regular Reader
2 hours ago
Positive momentum remains visible, though technical levels should be monitored.
👍 155
Reply
2
Taybree
Consistent User
5 hours ago
This kind of delay always costs something.
👍 175
Reply
3
Breahanna
Legendary User
1 day ago
Ah, regret not checking sooner.
👍 71
Reply
4
Joziel
Community Member
1 day ago
This feels like something important is happening elsewhere.
👍 115
Reply
5
Starlisa
Legendary User
2 days ago
Free US stock valuation multiples and PEG ratio analysis to identify reasonably priced growth companies. Our valuation framework helps you find stocks with the right balance of growth and value characteristics.
👍 104
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.